Cancer Research & Treatment Fund Inc
- Assets
- $13.7m
- Revenue
- $1.0m
- Investments
- $6.9m
- Employees
- 3
- Location
- New York, NY
- Founding
- 06/1968
- Data as of
- 12/2023
- EIN
- 13-6272085
Organization Overview
Cancer Research & Treatment Fund Inc is located in New York, NY. The organization was established in 1968. According to its NTEE Classification (H30) the organization is classified as: Cancer Research, under the broad grouping of Medical Research and related organizations. As of 12/2023, Cancer Research & Treatment Fund Inc employed 3 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Cancer Research & Treatment Fund Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Cancer Research & Treatment Fund Inc generated $1.0m in total revenue. This represents relatively stable growth, over the past 9 years the organization has increased revenue by an average of 0.2% each year. All expenses for the organization totaled $1.0m during the year ending 12/2023. You can explore the organizations financials more deeply in the financial statements section below.
Since 2017, Cancer Research & Treatment Fund Inc has awarded 12 individual grants totaling $3,562,235. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
TO PROVIDE RESOURCES FOR STATE OF THE ART RESEARCH THAT LEADS TO EFFECTIVE TREATMENT OF CANCERS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
RESEARCH AND GRANTS MADE FOR CANCER CARE AND CURE.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Richard Tsilver MD Director | OfficerTrustee | 40 | $120,000 |
David Boule Director | OfficerTrustee | 3 | $0 |
Richard Rose Director | Trustee | 1 | $0 |
Todd Shaw Director | Trustee | 1 | $0 |
Adam Silver Director | Trustee | 1 | $0 |
Jeffrey Puglisimd Director | Trustee | 0 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $609,755 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $160,145 |
| Noncash contributions included in lines 1a–1f | $5,936 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $769,900 |
| Total Program Service Revenue | $0 |
| Investment income | $132,648 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $249,730 |
| Net Income from Fundraising Events | -$125,864 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $1,026,414 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $545,450 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $120,000 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $143,398 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $22,580 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $15,354 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $31,212 |
| Advertising and promotion | $0 |
| Office expenses | $49,608 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $44,419 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $10,655 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $2,767 |
| Insurance | $0 |
| All other expenses | $0 |
| Total functional expenses | $1,011,255 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $23,607 |
| Savings and temporary cash investments | $578,808 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $6,090,692 |
| Investments—other securities | $6,947,761 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $107,442 |
| Total assets | $13,748,310 |
| Accounts payable and accrued expenses | $21,250 |
| Grants payable | $240,000 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $94,653 |
| Total liabilities | $355,903 |
| Net assets without donor restrictions | $13,392,407 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $13,748,310 |
Grants Awarded
Over the last fiscal year, Cancer Research & Treatment Fund Inc has awarded $524,500 in support to 2 organizations.
| Grant Recipient | Amount |
|---|---|
THE FUND FOR BLOOD AND CANCER PURPOSE: CANCER RESEARCH | $5,100 |
WEILL CORNELL MEDICAL COLLEGE PURPOSE: RESEARCH- MYELOPROLIFERATIVE NEOPLA | $519,400 |